Financial Performance - The group's unaudited revenue for the three months ended March 31, 2019, was approximately SGD 1,762,000, a decrease of about SGD 63,000 or 3.5% compared to the same period in 2018[5]. - The group's unaudited profit for the three months ended March 31, 2019, was approximately SGD 298,000, an increase of about SGD 5,000 or 1.7% compared to the same period in 2018[5]. - Basic earnings per share for the three months ended March 31, 2019, remained at 0.05 Singapore cents, unchanged from the same period in 2018[5]. - The group's pre-tax profit for the three months ended March 31, 2019, was SGD 368,000, compared to SGD 388,000 for the same period in 2018[7]. - Total comprehensive income attributable to owners of the company for the three months ended March 31, 2019, was SGD 298,000, compared to SGD 293,000 for the same period in 2018[7]. - The total revenue for the first quarter of 2019 was approximately SGD 1,762,000, a decrease of about SGD 63,000 or 3.5% compared to SGD 1,825,000 in the same period of 2018[48]. - The company reported a pre-tax profit of SGD 298,000 for the first quarter of 2019, compared to SGD 293,000 in the same period of 2018[45]. - Profit for the three months ended March 31, 2019, was approximately SGD 298,000, a decrease of about SGD 5,000 compared to SGD 293,000 for the same period in 2018[75]. Revenue Breakdown - Revenue from consultation services was SGD 488,000, accounting for 27.7% of total revenue, while prescription and dispensing services generated SGD 495,000, representing 28.1%[48]. - Revenue from consultation services increased by approximately SGD 25,000 to about SGD 488,000, with the total number of patients rising from 5,239 to 5,587, representing a growth of 6.6%[57]. - Revenue from prescription and dispensing services decreased by approximately SGD 69,000 to SGD 495,000, primarily due to reduced sales of DS brand skincare products[57]. - Revenue from treatment services decreased by SGD 20,000 to approximately SGD 658,000, mainly due to a decline in procedures involving anesthesia and intense pulse light[57]. Operating Expenses and Tax - The group incurred total operating expenses of SGD 614,000 for the three months ended March 31, 2019, down from SGD 708,000 in the same period in 2018[7]. - The group’s tax expense for the three months ended March 31, 2019, was SGD 70,000, compared to SGD 95,000 for the same period in 2018[7]. - Tax expenses for the three months ended March 31, 2019, were approximately SGD 70,000, down from SGD 95,000 for the same period in 2018, mainly due to a decrease in pre-tax profit[74]. Corporate Governance - The board of directors did not recommend any dividend payment for the three months ended March 31, 2019[5]. - The company did not declare any dividends for the quarter ending March 31, 2019, consistent with the previous year[46]. - The board of directors confirmed compliance with the trading code for directors during the three months ended March 31, 2019[92]. - The company has adopted the corporate governance code as per GEM Listing Rules and has complied with all applicable provisions during the reporting period[86]. - The board is committed to maintaining high standards of corporate governance to enhance transparency and accountability[86]. Market Expansion and Strategy - The company plans to expand its market share in the dermatology and surgical services sector in Singapore, focusing on enhancing its brand and business growth[51]. - A new medical aesthetic clinic was opened in February 2019 at the same property as the existing Orchard Clinic, aimed at developing the medical aesthetic business[51]. - The company is seeking to expand the "Family and Skin" clinics, which will focus on treating less complex skin conditions, thereby increasing patient referrals to existing clinics for more complex treatments[52]. Shareholding and Interests - As of March 31, 2019, Loh Teck Hiong, Ee Hock Leong, and Koh Yong Jian collectively own 358,000,000 shares, representing 59.66% of the company's equity[77]. - Brisk Success Holdings Limited, controlled by the aforementioned individuals, holds the 358,000,000 shares, with each individual having a beneficial ownership of approximately 33.33%[82]. - Victory Spring Ventures Limited holds 35,560,000 shares, accounting for 5.93% of the company's equity, with Ye Zhi Chun as the beneficial owner[81]. - The company has not issued any share options since the adoption of the share option plan on September 22, 2017[87]. - No shares were purchased, sold, or redeemed by the company or its subsidiaries during the three months ended March 31, 2019[90]. Compliance and Audit - The audit committee, established on September 22, 2017, consists of three independent non-executive directors and is responsible for reviewing the company's financial reporting procedures and internal control systems[100]. - As of March 31, 2019, there were no interests held by the company's directors or controlling shareholders in any business that competes or may compete with the group[95]. - The compliance advisor confirmed that, as of March 31, 2019, there were no interests related to the group that needed to be disclosed under GEM Listing Rules[96]. - The independent non-executive directors reviewed the implementation of the non-competition agreement and found compliance by the controlling shareholders for the three months ended March 31, 2019[94].
德斯控股(08437) - 2019 Q1 - 季度财报